Skip to main content

The rockefeller university

News & HighlightsNews
Markus Library prepares researchers for new NIH data management policy
The library is offering new tools and training to support researchers operating under an updated NIH policy.
How a cell's mitochondria make their own protein factories
The findings shed a rare light on mitoribosomes, the unique ribosomes found within the cell's mitochondria.
How antibody therapy impacts COVID vaccines
People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition.
Research on rare genetic disease sheds light on a common head and neck cancer
Patients with Fanconi anemia have an elevated risk for squamous cell carcinoma, a highly aggressive head-and-neck cancer. New findings pinpoint the mechanisms linking the two conditions, and also shed new light on how smoking or drinking may elevate anyone’s cancer risk.
Cancer stem cells are fueled through dialogue with their environments
The findings suggest that many of the mutations in cancer may simply be setting in stone a path already forged by the tumor stem cell’s aberrant dialogue with its surroundings.
Ant pupae secrete fluid as "milk" to nurture young larvae
This newly discovered “social fluid” appears to unite ant colonies across developmental stages into one superorganism.
A new institute devoted to research on global infectious disease is funded by a $75 million grant
Rockefeller’s new Stavros Niarchos Foundation Institute for Global Infectious Disease Research will provide a framework for international scientific collaboration.
Eight Rockefeller scientists designated most influential researchers
Clarivate, a British analytics company, recognizes individuals "who demonstrate significant and broad influence among their peers in their chosen field or fields of research."
From the piano bench to the lab bench
Gabriel D. Victora is unlocking the mysteries of how the body generates antibodies to defend itself from pathogens. But there was a time when science was not even on his radar.
Promising new drug target for a rare liver cancer
Fibrolamellar carcinoma needs one specific mutation in order to thrive, and impeding it reduces tumor growth in mice.
View
View